Future of Life Sciences
Invited by the Swiss AmCham New York Chapter
A dialogue on building resilient innovation across the pharmaceutical development lifecycle.
Join the Swiss AmCham New York Chapter for an evening discussion on the future of the life sciences industry, hosted by the Swiss-American Chamber of Commerce, New York Chapter, in partnership with RSM US LLP and Swiss Business Hub USA.
The conversation will feature Kimberly Harrelson, Vice President and Head of Ethics & Compliance at Lonza, and further representatives of the MedTech and broader pharmaceutical development lifecycle space. The conversation will be moderated by Amanda Laskey, Life Sciences Senior Analyst and Senior Manager at RSM US LLP.
The life sciences sector faces mounting pressure from geopolitical shifts, evolving regulations, and supply chain complexity — all while the pace of scientific and technological change accelerates. How can organizations build resilience without sacrificing innovation?
This evening brings together leaders from med-tech, development, manufacturing, and distribution for a candid conversation on staying competitive in an uncertain world.